News

BioStat® Research
& Development Centre

2024 2023 2022 older
Study of new solutions in surgery for Corza Medical
26
August
2024
Study of new solutions in surgery for Corza Medical
The Biostat Research and Development Center has signed an agreement with Corza Medical to conduct a PASS study in the...
Aneta Piechaczek, Phd from Biostat co-authors a wcientific article
21
August
2024
Aneta Piechaczek, Phd from Biostat co-authors a wcientific article
Marek Kluszczyński, MD, who specializes in the rehabilitation of children and adolescents, has published a scientific...
Biostat will conduct a medical experiment for Stallergenes Greer
17
July
2024
Biostat will conduct a medical experiment for Stallergenes Greer
Biostat Research and Development Center has signed an agreement with a pharmaceutical company Stallergenes Greer to c...
Cooperation of Biostat and Medinice. Doctors used the CoolCryo system during surgery
09
July
2024
Cooperation of Biostat and Medinice. Doctors used the CoolCryo system during surgery
The innovative CoolCryo® system for cardiac cryoablation, for which Biostat is conducting a clinical trial,...
Biostat will conduct a non-interventional study for Adamed Pharma
27
June
2024
Biostat will conduct a non-interventional study for Adamed Pharma
A non-interventional study among cardiology patients - this is a new field of cooperation between the Biostat R...
Biostat listed in the Forbes ranking
21
May
2024
Biostat listed in the Forbes ranking
For another year in a row, Biostat Research and Development Center has been recognized in the ranking of the most dyn...
Biostat and MSD Polska collaborate on lung cancer study
16
May
2024
Biostat and MSD Polska collaborate on lung cancer study
The Biostat Research and Development Centre starts cooperation with the MSD Polska pharmaceutical company. ...
Post-stroke aphasia. Biostat in a clinical trial in the US
15
February
2024
Post-stroke aphasia. Biostat in a clinical trial in the US
Biostat's Research and Development Center has prepared a randomization system for a clinical trial being conducte...
It's been a good year! Summary of 2023 at Biostat
12
February
2024
It's been a good year! Summary of 2023 at Biostat
It's been a good year! Summary of 2023 at Biostat We summarize 2023 at Biostat Group. We are p...
26
August
2024
Study of new solutions in surgery for Corza Medical
26
August
2024

Study of new solutions in surgery for Corza Medical

The Biostat Research and Development Center has signed an agreement with Corza Medical to conduct a PASS study in the area of surgery.

 

The PASS study (Post Authorization Safety Study) will concern the use of human Fibrinogen and human Thrombin in paediatric patients during surgical procedures.

 

- We will be responsible for the comprehensive management of the study, i.e. obtaining the consent of regulatory bodies to conduct the study, contracting centers, eCRF, statistics, monitoring and project management

– enumerates Edyta Klemba - Pharma Division Director at Biostat.

 

Corza Medical is a leading global manufacturer of innovative surgical technologies and solutions, enabling customers and partners to deliver exceptional surgical care, improving patient outcomes worldwide.  Learn more at https://corza.com/

See also
Biostat will conduct a non-interventional study for Adamed Pharma Biostat will conduct a non-interventional study for Adamed Pharma
A non-interventional study among cardiology patients - this is a new field of cooperation between the Biostat R...
BioStat® among the 50 Most Creative in Business! BioStat® among the 50 Most Creative in Business!
Our project "Digitalization and Machine Learning in healthcare" dedicated to the Polish and international m...
Training, consulting, BioStat® experts statistics Training, consulting, BioStat® experts statistics
Clinical and observational trials have been carried out by our company for years. The eCRF.bizTM system which is mos...
eCRF.biz™ system conquers the Polish market eCRF.biz™ system conquers the Polish market
BioStat® is a brand not only known for statistics and analyses. Our company position has significantly changed in...
Copyright© 2023 Biostat